Allworth Financial LP Repligen Corp Transaction History

Allworth Financial LP

$15.5 Billion
Q2 2024

A detailed history of Allworth Financial LP transactions in Repligen Corp stock. As of the latest transaction made, Allworth Financial LP holds 1,582 shares of RGEN stock, worth $230,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,582

Previous 2,210 28.42%

Holding current value

$230,861

Previous $406,000 50.99%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$120.0 - $182.95 $75,360 - $114,892	-628 Reduced 28.42%	1,582 $199,000
Q1 2024 Apr 25, 2024	BUY	$170.78 - $208.42 $353,002 - $430,804	2,067 Added 1445.45%	2,210 $406,000
Q4 2023 Jan 24, 2024	SELL	$114.17 - $185.35 $15,070 - $24,466	-132 Reduced 48.0%	143 $25,000
Q3 2023 Oct 31, 2023	BUY	$138.78 - $176.51 $1,942 - $2,471	14 Added 5.36%	275 $43,000
Q2 2023 Jul 18, 2023	SELL	$138.42 - $180.31 $968 - $1,262	-7 Reduced 2.61%	261 $36,000
Q1 2023 Apr 18, 2023	BUY	$154.26 - $198.1 $925 - $1,188	6 Added 2.29%	268 $45,000
Q4 2022 Jan 13, 2023	BUY	$162.42 - $220.56 $16,404 - $22,276	101 Added 62.73%	262 $0
Q3 2022 Oct 18, 2022	BUY	$160.42 - $256.21 $2,566 - $4,099	16 Added 11.03%	161 $30,000
Q2 2022 Jul 13, 2022	BUY	$140.68 - $188.02 $20,257 - $27,074	144 Added 14400.0%	145 $24,000
Q1 2022 Apr 22, 2022	SELL	$161.19 - $257.96 $16,119 - $25,795	-100 Reduced 99.01%	1 $0
Q4 2021 Jan 21, 2022	SELL	$247.59 - $304.47 $1,237 - $1,522	-5 Reduced 4.72%	101 $27,000
Q3 2021 Nov 02, 2021	BUY	$194.77 - $324.21 $7,011 - $11,671	36 Added 51.43%	106 $31,000
Q1 2021 Apr 29, 2021	BUY	$180.37 - $226.26 $12,625 - $15,838	70 New	70 $14,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

53.9M

Call Options Held

420K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Account

Allworth Financial LP Repligen Corp Transaction History